Fordecades, it has been known that the mutations in the tumor suppressor genes BRCA1 and BRCA2 are associated with high risks of breast and ovarian cancer,but a new prospective cohort study provides the strongest evidence to date thatthese mutations are associated with the development of prostate cancer (PCa).
TheBRCA2 mutation appears to be morestrongly associated with PCa development than the BRCA1 mutation. In addition, the increased risk of PCa varies byfamily history of the malignancy and the location of the mutation within thegenes.
Ourstudy is unique in that we have recruited healthy men across the UK and Irelandwho have hereditary BRCA1 or BRCA2 mutations, and then followed themprospectively for up to 17 years to see if they would develop prostate cancer,said corresponding author Tommy Nyberg, a PhD candidate at the Centre forCancer Genetic Epidemiology at the University of Cambridge in the UK.
Thestudy, which was published in EuropeanUrology, included 376 male BRCA1 mutationcarriers and 447 male BRCA2 mutation carrierswho were identified in clinical genetics centers in the United Kingdom and Ireland.Of these, 16 BRCA1 and 26 BRCA2carriers were diagnosed with PCa during follow-up. Nyberg and his colleagues foundthat the risk of PCa is more strongly influenced by BRCA2 than BRCA1 mutations.The BRCA2 mutation is associated witha nearly 4.5-fold increased risk of PCa, whereas the BRCA1 mutation is associated with an approximately 2.4-foldincreased risk. This translates into estimated absolute lifetime risks fordeveloping prostate cancer of 60% for BRCA2and 29% for BRCA1 mutation carriers.We also found an association with more aggressive prostate cancer for men with BRCA2, but not BRCA1 mutations, Nyberg told Renal& Urology News.
Forthe men with BRCA1/2 mutations, therisk was greater for those from families where several family members had beendiagnosed with PCa than for those without such a family history. This probablyreflects the complex genetic landscape of prostate cancer susceptibility, withseveral genetic variants besides BRCA1/2mutations being known to influence the risk, Nyberg said.
Amongcarriers of the BRCA2 mutation, therisk of PCa increased nearly 1.7-fold with each relative diagnosed with PCa.Compared with the general population, BRCA2mutations in the so-called ovarian cancer cluster region (bounded by positionsc.2831 and c.6401) were associated with a nearly 2.5-fold higher incidence ofPCa, a lower risk increase than for mutations elsewhere in the BRCA2 gene. BRCA2 mutations outside this region were associated with a 5.9-foldrelative risk of PCa. Additionally, the BRCA2mutation was associated with a 5-fold increased incidence of Gleason score 7PCa and 3-fold increased incidence of Gleason 6 or less PCa. The mutation alsowas associated with almost 3.9-fold increased incidence of PCa mortality.
Isee the primary clinical application of our research as facilitating geneticcounseling and the early detection of prostate cancer, Nyberg said. Men whoare discovered to carry a hereditary BRCA2mutation, even if currently healthy, are at considerable risk of developingprostate cancer during their lifetime. A greater understanding of genetic riskvariants is continuously occurring, and consequently genetic counseling forprostate cancer is getting more and more accurate.
AnthonyV. DAmico, MD, PhD, Chief of the Division of Genitourinary Radiation Oncologyat Dana-Farber Cancer Institute and Professor of Radiation Oncology at HarvardMedical School in Boston said drugs already are available that target BRCA2 mutations. Studies are needed inmen who harbor BRCA mutations to investigate whether these drugs such as PARPinhibitors and platnium based chemotherapy can reduce the risk of metastasisand death from prostate cancer, Dr DAmico said.
Moreover,the new findings support recommendations that men with a significant familyhistory for PCa, especially those with multiple first-degree relatives with PCa,undergo genetic testing for the BRCA2mutation and then to be seen by a genetics counselor to be considered for screening at an earlier age than recommendedin standard guidelines.
Themajor implication here is that men with BRCA2in particular are at a significantly increased risk of developing clinicallymeaningful prostate cancer, and this risk might be influenced by factors suchas family history and the type of mutation that is inherited, said Amar U.Kishan, MD, Assistant Professor of Radiation Oncology at the David GeffenSchool of Medicine of UCLA.
Althoughthe therapeutic implications of the new findings are unclear, it istheoretically possible that men with mutations in DNA repair genes may derivebenefit from drugs such as poly (ADP-ribose) polymerase (PARP) inhibitors, butthe data to support such a strategy are limited to patients with advanced,metastatic castration-resistant PCa. In this setting, olaparib and rucaparibare approved for men with BRCA1/2mutant-tumors, though these mutations can be either inherited or restricted tothe tumor, Dr Kishan said. Whether men with an inherited BRCA2 mutation, whodevelop an aggressive but early stage prostate cancer, would benefit from thistype of therapy, in combination with surgery or radiotherapy, is not known.Several studies are investigating this concept.
ToddMorgan, MD, Associate Professor of Urology and Chief of the Division ofUrologic Oncology at the University of Michigan in Ann Arbor, said the new studyadds important data to help guide patient counseling and may allow for improvedearly detection strategies in men with BRCA1/2 mutations. At his institution, DrMorgan and his colleagues have implemented an early detection clinic for menwith BRCA1 or BRCA2 mutations, which is modeled after similar clinics for femalecarriers of these mutations (https://www.rogelcancercenter.org/cancer-genetics/prostate-cancer-risk-clinic).
Medicaloncologist David Wise, MD, PhD of NYU Langone Health in New York, said the newfindings may change the conversation for men carrying the BRCA2 germline mutation. Based on this study and others, newguidelines are needed to personalize prostate cancer screening for men carryingthe BRCA2 germline mutation. Clinicaltrials testing PARP inhibitors, already FDA approved for ovarian and breastcancer, are ongoing in BRCA2-associatedprostate cancer. Based on promising data from these clinical trials, the FDAhas granted breakthrough therapy status for two PARP inhibitors, rucaparib andolaparib, for men with castration-resistant prostate cancer, Dr Wise said.
Reference
NybergT, Frost D, Barrowdale D, et al. Prostate cancer risks for male BRCA1 andBRCA2 mutation carriers: A prospective cohort study [published online September5, 2019]. Eur Urol. https://doi.org/10.1016/j.eururo.2019.08.025
The rest is here:
Prospective Study Characterizes PCa Risk Linked to BRCA1, BRCA2 Mutations - Renal and Urology News
- Home Page of the Human Gene and Cell Therapy Center [Last Updated On: August 29th, 2015] [Originally Added On: August 29th, 2015]
- Gene Therapy: Chinese Researching Gene Replacement [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Medi-Cal: Medi-Cal Update - Clinics and Hospitals | May ... [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Gene Therapy Market - Size, Share, industry, Forecast ... [Last Updated On: November 30th, 2016] [Originally Added On: November 30th, 2016]
- Digital Journal: A Global Digital Media Network - Digital Journal (press release) [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Cure for ageing could lie in gene therapy | WIRED UK [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Advanced Gene-Targeted Therapies - Alternative Cancer Clinics [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Alternative Cancer Clinics - Immunotherapy for Cancer [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Stem cell therapies breaking barriers - Guardian (blog) [Last Updated On: July 9th, 2017] [Originally Added On: July 9th, 2017]
- Cancer Biological Therapy market is rising with potential rate at CAGR of 4.7 % till 2023 - MENAFN.COM [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Head and Neck Cancer Therapeutics Market is Expected to Generate Huge Profits by 2024 - MilTech [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- In a first, scientists edit fatal gene mutation out of DNA - Asheboro Courier Tribune [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Proton Therapy: How It Could Change The Outcome of Paediatric Cancer - HuffPost [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Wilson's Disease Market: Unmet Needs of Patient Population to Inspire Players for Improved Treatment Options - Edition Truth [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Cardiovascular disease cure? One session of THIS could help treat condition - Express.co.uk [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Understanding the muscle behind global duchenne muscular dystrophy market - WhaTech [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Biological bypass shows promise in coronary artery disease - Medical Xpress [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- Sodium Iodide Symporter for Nuclear Molecular Imaging and ... [Last Updated On: August 13th, 2017] [Originally Added On: August 13th, 2017]
- Traditional Therapy Clinics Ltd (TTC.AX) Money Flow Index Levels in Focus - Stock Daily Review [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Gene Editing in Human Embryos Leaps ForwardHere's the Science - Singularity Hub [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Global Cancer Biological Therapy Market 2017 Size, Development Status, Type and Application, Segmentation ... - Digital Journal [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Orphan Diseases Market Key Players analysis ... - Digital Journal - Digital Journal [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- New Stanford drug saves child with deadly genetic disease - The Mercury News [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- Australian Market Declines - Markets Insider [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- How one California county is fighting high-priced surgeries - Los Angeles Times [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- New 'hit-and-run' gene editing tool temporarily rewrites genetics to treat cancer and HIV - GeekWire [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Global Cancer Biological Therapy Analysis & Forecast 2016 to 2023 - Digital Journal [Last Updated On: September 5th, 2017] [Originally Added On: September 5th, 2017]
- FDA Approves New Cancer Treatment - Alive For Football [Last Updated On: September 5th, 2017] [Originally Added On: September 5th, 2017]
- FDA approves first cell-based gene therapy for use in the United States - Gears Of Biz [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Quick Hits: Withdrawn Leukemia Drug Returning, Drugmaker in $58M Settlement Over Sales Reps, and More - MedShadow (registration) (blog) [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Hacking Your Genes Has Never Been Easier - Outside Magazine [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- resurrection-clinics.eu [Last Updated On: August 24th, 2018] [Originally Added On: August 24th, 2018]
- Cell and Gene Therapy Center - IQVIA [Last Updated On: December 24th, 2018] [Originally Added On: December 24th, 2018]
- F.D.A. Speeds Review of Gene Therapies, Vowing to Target ... [Last Updated On: February 17th, 2019] [Originally Added On: February 17th, 2019]
- Nutrition : The Addiction Recovery Guide [Last Updated On: March 25th, 2019] [Originally Added On: March 25th, 2019]
- Gene Therapy: The New Frontier for Inherited Retinal Disease [Last Updated On: April 16th, 2019] [Originally Added On: April 16th, 2019]
- 4 Barriers To Cell And Gene Therapy Development For Rare ... [Last Updated On: May 18th, 2019] [Originally Added On: May 18th, 2019]
- Google Bans Advertising on Unproven Medical Treatments (like Stem Cells) - Bedford Bulletin [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Biological Product Manufacturing Market Analysis, Size, Regional Outlook, Share, Trend, Growth, Analysis and Forecast - Rapid News Network [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Precision Cancer Therapies Market to Witness Comprehensive Growth by 2017 2025 - Technology Trend [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Targeted Cancer Therapies Market Regional Landscape, Production, Sales & Consumption Status and Prospects 2025 - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Chemotherapy Drugs Market Strategies, Major Industry Participants, Marketing Channels and Forecast To2018 2028 - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Texas State To Expand Round Rock Campus Programs, Services - Round Rock, TX Patch [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Transfusion-dependent Anemia Treatment Market Size, Status and Growth Opportunities by 2025 - The Market Plan [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Google bans ads for 'bad actors' selling 'deceptive treatments' - BioEdge [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Precision Cancer Therapies Market Forecast Research Reports Offers Key Insights 2017 2025 - Space Market Research [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Nearly Half of Poland's SMA Patients on Track to Get Spinraza, Experts Say - SMA News Today [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Pollard and Norris in the race for Pos. 2 of the Public Hospital District 4 - Snoqualmie Valley Record [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Social Impact Heroes: How Lynn OConnor Vos and the Muscular Dystrophy Association are helping to raise billions of dollars to fund research to... [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Non-viral Gene Therapy will now accelerate cancer study - Industry Reporter [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Transfusion-dependent Anemia Treatment Market Gain Impetus due to the Growing Demand over 2019 2029 - Herald Space [Last Updated On: October 1st, 2019] [Originally Added On: October 1st, 2019]
- Parkinsons Disease Treatment Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2025 - The Ukiah Post [Last Updated On: October 11th, 2019] [Originally Added On: October 11th, 2019]
- The Patient Perspective On Patient Centricity Insights From A Veteran Of 5 Clinical Trials - Clinical Leader [Last Updated On: October 12th, 2019] [Originally Added On: October 12th, 2019]
- Deepak Chopra Has Never Been Sick - The New Yorker [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Dr Batra's have launched a new genetics-based therapy that predicts future diseases - Gulf Today [Last Updated On: October 31st, 2019] [Originally Added On: October 31st, 2019]
- Davenport & Company Upped By $3.56 Million Its Sgmo (SGMO) Holding; EMPOWER CLINICS ORDINARY SHARES (EPWCF) Shorts Raised By 2360% - MS Wkly [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Global Cell Therapy Technologies Market Industry Analysis And Forecast (2018-2026) - The Market Expedition [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Tip Sheet: A clever way to make an AIDS vaccine; how a common cancer mutation actually drives cancer; and a new process that regulates red blood cell... [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Anti-Aging Products and Therapies Market Outlook: Investors Still Miss the Big Assessment - The Market Journal [Last Updated On: November 11th, 2019] [Originally Added On: November 11th, 2019]
- Abuse in cell banking services a global problem - Bioprocess Insider - BioProcess Insider [Last Updated On: November 14th, 2019] [Originally Added On: November 14th, 2019]
- Hemophilia Treatment Market Dynamics, Pin-Point Analysis, Comprehensive Landscape, Demand Key Factors, Market Segments Regions, Therapy For Hemophilia... [Last Updated On: November 18th, 2019] [Originally Added On: November 18th, 2019]
- U.S. stem cell clinic offering unapproved therapies brings direct-to-consumer marketing to Ottawa - Ottawa Citizen [Last Updated On: November 18th, 2019] [Originally Added On: November 18th, 2019]
- Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT - Yahoo Finance [Last Updated On: November 20th, 2019] [Originally Added On: November 20th, 2019]
- Macular Degeneration Treatment Market and its Future Outlook and Trend During the Period of 2019 2026 - The Chicago Sentinel [Last Updated On: November 25th, 2019] [Originally Added On: November 25th, 2019]
- Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference - Thehour.com [Last Updated On: November 28th, 2019] [Originally Added On: November 28th, 2019]
- Global Parkinsons Disease Treatment Market 2019 Analysis by Industry Growth, Size, Share, Trends and Forecast by 2025 - Eastlake Times [Last Updated On: November 30th, 2019] [Originally Added On: November 30th, 2019]
- World AIDS Day 2019: 37.9M people worldwide were living with HIV at the end of 2018 - USA TODAY [Last Updated On: December 2nd, 2019] [Originally Added On: December 2nd, 2019]
- Precision Cancer Therapies Market Size, Status and Forecast 2025 Trends, Size, Drivers, Strategies, Products and - The Market Stats News [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Counterculture 73: Summer Jam, Timothy Leary and the Sexual Revolution - Rolling Stone [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Cancer gene therapy backed by Blackstone gets trial win - BioPharma Dive [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Parkinsons Disease Treatment Market 2019- Global Industry Analysis, by Key Players, Segmentation, Application, Demand and Forecast by 2025 - Tribunal... [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Mergers and Acquisitions Will Strengthen Payer Identity in 2020 - HealthPayerIntelligence.com [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- University of Iowa researchers say $18 million grant could soon lead to cure for rare brain disease - KCRG [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- ICMR issues guidelines for gene therapy in India - Daily Pioneer [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- US Network of Specialized Angelman Clinics to Double Thanks to New Partnership - Angelman Syndrome News [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- This was the best health news over the last decade - USA TODAY [Last Updated On: December 18th, 2019] [Originally Added On: December 18th, 2019]
- Top Providers of the Alpha Thalassemia Market gives a New Dimension easing Measurement and Quantification - GuruFocus.com [Last Updated On: December 27th, 2019] [Originally Added On: December 27th, 2019]
- Novel discovery in gene therapy to treat kidney diseases - WeForNews [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Insights on precision oncology developments in Japan and beyond - MobiHealthNews [Last Updated On: January 6th, 2020] [Originally Added On: January 6th, 2020]
- Cell Harvesting Market is Expected to Reach USD 387.9 Million by 2025| Bertin, Tomtec, Terumo BCT, HynoDent AG, Avita Medical, Argos Technologies -... [Last Updated On: January 9th, 2020] [Originally Added On: January 9th, 2020]